Skip to main content
. 2021 Apr 19;2021(4):CD013792. doi: 10.1002/14651858.CD013792.pub2

IRCT20120104008611N9.

Study name Comparison of the effect of two progesteron drugs in protection of abortion
Methods 2‐arm active‐controlled randomised trial.
Participants Pregnant women with gestational age between 6 and 13 weeks, presence of a fetal heart beat, uterine bleeding and a closed uterine orifice. Exclusion criteria include embryonic or uterine anomalies identified by ultrasound, multi‐fetal hydatidiform mole, known underlying disease in mother, women who have been treated by a specific medication to treat abortion.
Interventions 400 mg daily vaginal progesterone versus 100 mg daily oral progesterone
Outcomes Abortion, pre‐eclampsia, gestational diabetes
Starting date 21‐Apr‐2018
Contact information hpakniat@qums.ac.ir
Notes